Sep 20, 2022· Comment from Association for Accessible Medicines (AAM)· FDA-2022-D-0528-0007
Comment letter submitted by the Association for Accessible Medicines (AAM) 19 Sept 2022
FDANonrulemakingFDA-2022-D-0528
Evaluation of Therapeutic Equivalence; Draft Guidance for Industry; Availability
RIN
—
Last modified
Sep 20, 2022
Comment window
closed 1408d ago
Association for Accessible Medicines filings
1
Activity
Association for Accessible Medicines filed 1 comment on this docket between Sep 20, 2022 and Sep 20, 2022. 0 other organizations filed here. The comment window closed 1408d ago.
What Association for Accessible Medicines filed (1)
Abstract
No abstract recorded.
View on regulations.gov →Co-filers (0)
See everyone who commented →- Association for Accessible MedicinesTHIS ORG1 filing · confidence 97%